|
Gentiva Health Services, headquartered in Long Island, New York, is one of the largest providers of health care and specialty pharmaceutical services in the United States.
A publicly traded NASDAQ: GTIV company,[1] Gentiva is a Fortune 1000 company with $870 million in annual revenue. Gentiva is also a member of the S&P 600 index, developed by Standard & Poor's, featuring small capitalization U.S.-based stocks.
Gentiva provides health services in nearly every state in the nation and maintains over 300 U.S. locations. According to Morningstar, "Gentiva is a gentle giant...the nation's largest home health care services firm."[2]
In 2002, Gentiva sold its specialty pharmaceutical services division, which administered infusion and injectable pharmaceuticals to patients with both acute and chronic disease, to Accredo Health Inc. for $415 million in cash and stock.[3] Accredo, in turn, was acquired by Medco (NYSE:MHS), a former division of Merck & Co., for $2.2 billion in February 2005.
In 2006, Gentiva acquired the Atlanta, Georgia-based Healthfield Group, a U.S. provider of home health and pharmaceutical services, for $454 million in cash and stock.[4] In 2008, Gentiva sold a majority stake of its benefit management business, CareCentrix, to Water Street Healthcare Partners, a Chicago-based private equity firm.[5]
References
External links
- Gentiva Health Services Official Web Site.
- Gentiva Health Services profile at NNDB.
- "Gentiva Considers Sale of Staffing Business", Home Health Provider, August 2, 2000.
- "Gentiva Health Services to Sell Staffing Unit", The New York Times, August 26, 2000.
- "Gentiva to Appeal Ruling", The New York Times, May 22, 2001.
- "City Plans Home Health Contract for Company Renamed After Fraud", The New York Times, July 10, 2001.
- "Customer Concerns Mount in Tragedy Aftermath", CRM Daily, September 12, 2001.
- "Feds Conclude Investigation of Payments to Gentiva", Long Island Business News, November 16, 2001.
- "Gentiva Makes $415M Deal", Newsday, January 3, 2002.
- Gentiva's 8-K SEC filing on sale of specialty pharmaceutical business, Edgar Online, January 7, 2002.
- "More Work to Do at Gentiva", Motley Fool, February 17, 2005.
| |
